BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Endo International (NASDAQ:ENDP) announced this morning that Clonidine Topical Gel failed to meet its primary endpoint in …
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating …
Roth Capital analysts weighed in on Galena Biopharma Inc (NASDAQ:GALE) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) following Q4:15 earnings from both companies.
Biotech stocks are notoriously volatile as a pipeline update or FDA announcement can instantly send share prices through the roof. Below, analysts weigh …
Healthcare analysts provided insight on both Relypsa Inc (NASDAQ:RLYP) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with bullish outlooks.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is up 16.
Roth Capital analyst Scott Henry weighed in today with his views on BioDelivery Sciences International, Inc.(NASDAQ:BDSI), after the company announced a supply constraint for its opioid dependence product …
In a research report issued Friday, William Blair analyst Tim Lugo reiterated a Buy rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with …
In a research report released Tuesday, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with a …
Janney Montgomery’s healthcare analyst Chiara Russo was out pounding the table on BioDelivery Sciences International, Inc. (NASDAQ:BDSI), reiterating a Buy rating and price target of …